Cite
HARVARD Citation
Powell, J. et al. (n.d.). Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates. British journal of haematology. pp. 113-123. [Online].